Abstract 4368654: Quantitative assessment of myocardial stiffness by three-dimensional ultrasound shear wave elastography in cardiac amyloidosis patients

Background: Cardiac Amyloidosis (CA), particularly transthyretin amyloidosis (ATTR) is characterized by the deposit of amyloid proteins in the extracellular matrix of myocardium leading to increased myocardial stiffness (MS) and impaired diastolic function. Previous studies have shown that 2D ultrasound shear wave elastography (SWE) can quantify non-invasively myocardial shear wave velocity (SWV) characterizing its stiffness. However, myocardium is a tri-dimensional tissue with a helicoidal fiber structure associated to anisotropic mechanical properties that vary over cardiac cycle. Therefore, accurately measuring MS in diastasis phase, under passive stiffness, requires a 3D approach with ECG gating. Purpose: We aim to demonstrate the feasibility of 3D-SWE for the quantification of diastolic MS in ATTR-CA patients. Methods: This prospective cohort study included 12 patients with diagnosed ATTR-CA (primary exposure variable) patients that received a standard echocardiographic examination and 3D-SWE. A customized ultrasound device based on a matrix transducer was used to perform 3D-SWE (Fig A) measuring SWV, primary outcome variable, in a myocardial volume of 10x16x16mm 3 (Fig C). Positioning was guided by real-time 2D B-mode and acquisitions were trigged during diastasis phase using ECG gating (Fig B). SWV was assessed in 3 myocardial regions: anterior free wall of the right ventricle (RV), basal antero-septal wall (AS) and apex, with 10 acquisitions per segment, totaling 360 transthoracic 3D-SWE acquisitions. Inter-operator variability was evaluated in 3 patients by two sonographers. Results: 3D-SWE was successfully performed in all patients (82±6 years; 85% men; LVEF: 60±9%; E/E’: 14±7; IVS: 16±3mm and GLS: -11±4%), in the 3 myocardial regions. Median SWV (Q1-Q3) values were 2.85m/s (2.35–3.03) in RV, 5.24 m/s (4.71–5.72) in AS, and 1.24 m/s (1.04–1.56) at the apex. Mean absolute difference over measurements performed by the two sonographers was 0.22m/s (RV), 0.75m/s (AS) and 0.23m/s (apex) and Intra-Correlation Coefficient was 0.96. Conclusion: Feasibility and good reproducibility of 3D-SWE on ATTR-CA patients was demonstrated. SWV of AS and RV segments were higher than apex segment and MS values reported on healthy volunteer. This distribution of MS among the 3 segments is consistent with apical sparing reported using strain measurement. 3D-SWE has the potential to provide accurate MS assessment for early diagnosis and follow-up of CA patients.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-03
DOI
https://doi.org/10.1161/circ.152.suppl_3.4368654
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4368654: Quantitative assessment of myocardial stiffness by three-dimensional ultrasound shear wave elastography in cardiac amyloidosis patients

Olivier Pedreira, Mathieu Pernot, Toûka Meki, Michael Vion et al.
Circulation
Amyloidosis: Diagnosis, Treatment, Outcomes
article

Abstract 4368654: Quantitative assessment of myocardial stiffness by three-dimensional ultrasound shear wave elastography in cardiac amyloidosis patients

Olivier Pedreira, Mathieu Pernot, Toûka Meki, Michael Vion, Clément Papadacci, Mounira Kharoubi, E. Messas, Amira Zaroui, Thibaud Damy, Mickaël Tanter, Janie Hanrard
article en

Abstract

Background: Cardiac Amyloidosis (CA), particularly transthyretin amyloidosis (ATTR) is characterized by the deposit of amyloid proteins in the extracellular matrix of myocardium leading to increased myocardial stiffness (MS) and impaired diastolic function. Previous studies have shown that 2D ultrasound shear wave elastography (SWE) can quantify non-invasively myocardial shear wave velocity (SWV) characterizing its stiffness. However, myocardium is a tri-dimensional tissue with a helicoidal fiber structure associated to anisotropic mechanical properties that vary over cardiac cycle. Therefore, accurately measuring MS in diastasis phase, under passive stiffness, requires a 3D approach with ECG gating. Purpose: We aim to demonstrate the feasibility of 3D-SWE for the quantification of diastolic MS in ATTR-CA patients. Methods: This prospective cohort study included 12 patients with diagnosed ATTR-CA (primary exposure variable) patients that received a standard echocardiographic examination and 3D-SWE. A customized ultrasound device based on a matrix transducer was used to perform 3D-SWE (Fig A) measuring SWV, primary outcome variable, in a myocardial volume of 10x16x16mm 3 (Fig C). Positioning was guided by real-time 2D B-mode and acquisitions were trigged during diastasis phase using ECG gating (Fig B). SWV was assessed in 3 myocardial regions: anterior free wall of the right ventricle (RV), basal antero-septal wall (AS) and apex, with 10 acquisitions per segment, totaling 360 transthoracic 3D-SWE acquisitions. Inter-operator variability was evaluated in 3 patients by two sonographers. Results: 3D-SWE was successfully performed in all patients (82±6 years; 85% men; LVEF: 60±9%; E/E’: 14±7; IVS: 16±3mm and GLS: -11±4%), in the 3 myocardial regions. Median SWV (Q1-Q3) values were 2.85m/s (2.35–3.03) in RV, 5.24 m/s (4.71–5.72) in AS, and 1.24 m/s (1.04–1.56) at the apex. Mean absolute difference over measurements performed by the two sonographers was 0.22m/s (RV), 0.75m/s (AS) and 0.23m/s (apex) and Intra-Correlation Coefficient was 0.96. Conclusion: Feasibility and good reproducibility of 3D-SWE on ATTR-CA patients was demonstrated. SWV of AS and RV segments were higher than apex segment and MS values reported on healthy volunteer. This distribution of MS among the 3 segments is consistent with apical sparing reported using strain measurement. 3D-SWE has the potential to provide accurate MS assessment for early diagnosis and follow-up of CA patients.

CirculationVol. 152(Suppl_3)
Centre d’histoire de Sciences Po (FR), Hôpital Européen Georges-Pompidou (FR), Payot (France) (FR), Hôpital Européen (FR), Hôpitaux Universitaires Henri-Mondor (FR), Science et Médecine (France) (FR)
Openalex Percentile: Top 71%
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.